These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation. Szczeklik A; Sanak M; Undas A Circulation; 2001 Feb; 103(6):E33-4. PubMed ID: 11171808 [No Abstract] [Full Text] [Related]
3. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action]. Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091 [TBL] [Abstract][Full Text] [Related]
4. Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Undas A; Sanak M; Musial J; Szczeklik A Lancet; 1999 Mar; 353(9157):982-3. PubMed ID: 10459913 [No Abstract] [Full Text] [Related]
5. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa. Szczeklik A; Undas A; Sanak M; Frolow M; Wegrzyn W Br J Haematol; 2000 Sep; 110(4):965-7. PubMed ID: 11054089 [TBL] [Abstract][Full Text] [Related]
7. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation. Boudoulas KD; Cooke GE; Roos CM; Bray PF; Goldschmidt-Clermont PJ Arch Pathol Lab Med; 2001 Jan; 125(1):112-5. PubMed ID: 11151063 [TBL] [Abstract][Full Text] [Related]
8. [Pharmazie in unserer Zeit 4/2009]. Alban S; Dingermann T Pharm Unserer Zeit; 2009; 38(4):295. PubMed ID: 19572344 [No Abstract] [Full Text] [Related]
9. Ex vivo--in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A. Klinkhardt U; Kirchmaier CM; Westrup D; Graff J; Mahnel R; Breddin HK; Harder S Clin Pharmacol Ther; 2000 Mar; 67(3):305-13. PubMed ID: 10741635 [TBL] [Abstract][Full Text] [Related]
10. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. McKee SA; Sane DC; Deliargyris EN Thromb Haemost; 2002 Nov; 88(5):711-5. PubMed ID: 12428082 [No Abstract] [Full Text] [Related]
11. Dose-related efficacy of aspirin after coronary surgery in patients With Pl(A2) polymorphism (NCT00262275). Lim E; Carballo S; Cornelissen J; Ali ZA; Grignani R; Bellm S; Large S Ann Thorac Surg; 2007 Jan; 83(1):134-8. PubMed ID: 17184645 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955 [TBL] [Abstract][Full Text] [Related]
13. Genetic determinants of response to aspirin: appraisal of 4 candidate genes. Lordkipanidzé M; Diodati JG; Palisaitis DA; Schampaert E; Turgeon J; Pharand C Thromb Res; 2011 Jul; 128(1):47-53. PubMed ID: 21429568 [TBL] [Abstract][Full Text] [Related]
14. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination. Cooke GE; Liu-Stratton Y; Ferketich AK; Moeschberger ML; Frid DJ; Magorien RD; Bray PF; Binkley PF; Goldschmidt-Clermont PJ J Am Coll Cardiol; 2006 Feb; 47(3):541-6. PubMed ID: 16458133 [TBL] [Abstract][Full Text] [Related]
15. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo. Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595 [TBL] [Abstract][Full Text] [Related]
16. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660 [TBL] [Abstract][Full Text] [Related]
17. Comparative antiplatelet effects of aspirin, vapiprost and GR144053, a GPIIb/IIIa antagonist, with a special reference to the role of platelet microaggregates. Matsuno H; Kozawa O; Nagashima S; Kanamaru M; Uematsu T Br J Pharmacol; 1999 Jul; 127(5):1129-34. PubMed ID: 10455258 [TBL] [Abstract][Full Text] [Related]
18. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists. Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566 [TBL] [Abstract][Full Text] [Related]